🇺🇸 FDA
Patent

US 9095624

Modular transport platform for targeted delivery of therapeutic agents

granted A61KA61K41/0071A61K47/6415

Quick answer

US patent 9095624 (Modular transport platform for targeted delivery of therapeutic agents) held by Contango Partners Group, Inc. expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Contango Partners Group, Inc.
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K41/0071, A61K47/6415, A61K47/642, A61K47/6445